Quarter Period Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7712791

Concept 2018-06-01 to
2019-02-28
2017-06-01 to
2018-02-28
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
2,539,069,000 JPY
2,280,208,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-42,259,000 JPY
156,266,000 JPY
Foreign currency translation adjustment
-63,589,000 JPY
90,938,000 JPY
Remeasurements of defined benefit plans, net of tax
6,081,000 JPY
3,186,000 JPY
Other comprehensive income
-99,767,000 JPY
250,391,000 JPY
Comprehensive income
2,439,301,000 JPY
2,530,599,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,469,977,000 JPY
2,523,019,000 JPY
Comprehensive income attributable to non-controlling interests
-30,676,000 JPY
7,580,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.